Medicare Enrolled
Dr. Alan Martin, M.D.
Neurology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Martin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Martin
Dr. Alan Martin is a neurology in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Martin performed 34,844 Medicare services across 922 unique beneficiaries.
Between the years covered by Open Payments, Dr. Martin received a total of $14,945 from 71 pharmaceutical and/or device companies across 811 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Martin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in TX$ $14,945 industry payments
Medicare Practice Summary
Medicare Utilization ↗34,844
Medicare services
Top 2% in TX for neurology
922
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,742 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 22,340 | $38 | $125 |
| MRI contrast dye injection (gadoterate) | 10,600 | $0 | $1 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 448 | $16 | $60 |
| Office visit, established patient, complex (40-54 min) | 242 | $131 | $440 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 231 | $78 | $102 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 222 | $51 | $215 |
| Office visit, established patient (30-39 min) | 180 | $93 | $334 |
| Blood draw (venipuncture) | 95 | $8 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 93 | $23 | $95 |
| New patient office visit (45-59 min) | 69 | $118 | $500 |
| Nerve conduction, 9-10 studies | 54 | $164 | $715 |
| Mri scan of brain before and after contrast | 39 | $123 | $1,530 |
| Administration of chemotherapy into vein, 1 hour or less | 33 | $102 | $415 |
| Punch biopsy, each additional skin growth | 32 | $48 | $198 |
| Nerve conduction, 5-6 studies | 28 | $100 | $445 |
| Mri scan of upper spinal canal before and after contrast | 23 | $173 | $1,500 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 21 | $50 | $70 |
| Nerve conduction, 7-8 studies | 21 | $140 | $590 |
| Mri scan of blood vessels of head without contrast | 18 | $95 | $1,225 |
| Punch biopsy, first skin growth | 17 | $101 | $402 |
| New patient office visit, complex (60-74 min) | 15 | $142 | $630 |
| Needle measurement of electrical activity in trunk or head muscles | 12 | $67 | $96 |
| Nerve conduction, 11-12 studies | 11 | $198 | $800 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.2% high complexity
95.0% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,945
Total received (2018-2024)
Avg $2,135/year across 7 years
Top 21% in TX for neurology
71
Companies
811
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,886 (92.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$810 (5.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$249 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,171
2023$2,233
2022$2,328
2021$1,855
2020$1,279
2019$3,099
2018$1,981
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$1,114
Alnylam Pharmaceuticals Inc.
$1,025
Genentech USA, Inc.
$963
ABBVIE INC.
$860
Sunovion Pharmaceuticals Inc.
$811
Alexion Pharmaceuticals, Inc.
$706
UCB, Inc.
$645
ARGENX US, INC.
$600
GENZYME CORPORATION
$564
Novartis Pharmaceuticals Corporation
$525
Avanir Pharmaceuticals, Inc.
$488
Allergan Inc.
$473
ACADIA Pharmaceuticals Inc
$463
Lilly USA, LLC
$458
Amgen Inc.
$421
PFIZER INC.
$415
Teva Pharmaceuticals USA, Inc.
$348
Acorda Therapeutics, Inc
$294
Grifols USA, LLC
$254
Amylyx Pharmaceuticals, Inc.
$208
EMD Serono, Inc.
$201
Lundbeck LLC
$201
SK Life Science, Inc.
$199
Merz Pharmaceuticals, LLC
$178
Amneal Pharmaceuticals LLC
$168
Takeda Pharmaceuticals U.S.A., Inc.
$147
AbbVie Inc.
$128
Celgene Corporation
$123
Supernus Pharmaceuticals, Inc.
$118
MERZ NORTH AMERICA, INC.
$110
Horizon Therapeutics plc
$101
Adamas Pharmaceuticals, Inc.
$99
Avion Pharmaceuticals
$98
Biohaven Pharmaceutical Holding Company Ltd.
$94
Allergan, Inc.
$90
TG Therapeutics, Inc.
$90
Upsher-Smith Laboratories LLC
$82
Biohaven Pharmaceuticals, Inc.
$80
Mitsubishi Tanabe Pharma America, Inc.
$70
Janssen Pharmaceuticals, Inc
$67
Siemens Medical Solutions USA, Inc.
$64
CATALYST PHARMACEUTICALS, INC.
$63
CSL Behring
$50
Neurocrine Biosciences, Inc.
$48
Eisai Inc.
$48
Neurelis, Inc.
$39
Assertio Therapeutics, Inc.
$39
AbbVie, Inc.
$36
Kyowa Kirin, Inc.
$33
TG THERAPEUTICS, INC.
$33
Otsuka America Pharmaceutical, Inc.
$32
UPSHER-SMITH LABORATORIES LLC
$31
HOSPIRA, INC.
$26
ARBOR PHARMACEUTICALS, INC.
$25
Vanda Pharmaceuticals Inc.
$24
Harmony Biosciences Llc
$24
Octapharma USA, Inc.
$24
Ipsen Biopharmaceuticals, Inc
$22
NS Pharma, Inc.
$19
Boston Scientific Corporation
$19
Impax Laboratories, Inc.
$18
Medtronic USA, Inc.
$17
Mallinckrodt Enterprises LLC
$17
Avadel CNS Pharmaceuticals, LLC
$15
BOSTON SCIENTIFIC CORPORATION
$15
GE HEALTHCARE
$15
BANNER LIFE SCIENCES, LLC
$15
Greenwich Biosciences, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
HARMONY BIOSCIENCES LLC
$13
IMPEL PHARMACEUTICALS INC.
$13
Top 3 companies account for 20.8% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · COMIRNATY · COPAXONE · CREXONT · Cambia · DAYBUE · DUOPA · DYSPORT · Dhivy · EMGALITY · Enspryng · Epidiolex · Evrysdi · FABRY-DISEASE · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEADPOINT · LEMTRADA · LUMIZYME · LUMRYZ · LYRICA · Leqembi · MAYZENT · Mavenclad · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · PONVORY · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RELYVRIO · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · Skyclarys · Soliris · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VERSANT kPCR Molecular System SP · VILTEPSO · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · Wakix · XEOMIN · Xembify · Xeomin · ZEPOSIA · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $43 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
241
Per 100K population
9.3
County median income
$74,149
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER UPTOWN
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Martin is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Martin experienced with injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg?
Based on Medicare claims data, Dr. Martin performed 22,340 injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Martin receive payments from pharmaceutical companies?
Yes. Dr. Martin received a total of $14,945 from 71 companies across 811 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martin's costs compare to other neurologys in Dallas?
Dr. Martin's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Dallas
Browse neurologys in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in TX
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in TX
Which TX neurologys receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc..
By company
Alnylam Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Alnylam Pharmaceuticals Inc..
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology